礼来公司表示有意以IPO价格收购Veradermics最多4.9%流通股

美股速递
Feb 03

生物科技公司Veradermics, Inc.近日披露,全球制药巨头礼来公司已表明投资意向,计划在公司完成首次公开募股后,以发行价购入不超过总股本4.9%的普通股。这一战略投资若最终落地,将显著强化两家公司在皮肤病治疗领域的协同效应。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10